Cleared Traditional

MEDIBLEND (TM) CLINICAL BLOOD GAS MIXTURES (K882209) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K882209 · Linde Div. Union Carbide Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1988
Decision
68d
Days
Class 2
Risk

K882209 is an FDA 510(k) clearance for the MEDIBLEND (TM) CLINICAL BLOOD GAS MIXTURES. Classified as Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (product code CHL), Class II - Special Controls.

Submitted by Linde Div. Union Carbide Corp. (Somerset, US). The FDA issued a Cleared decision on August 2, 1988 after a review of 68 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1120 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Linde Div. Union Carbide Corp. devices

Submission Details

510(k) Number K882209 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 26, 1988
Decision Date August 02, 1988
Days to Decision 68 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 88d · This submission: 68d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

All 35
Devices cleared under the same product code (CHL) and FDA review panel - the closest regulatory comparables to K882209.
IL1430 BGELECTROLYTE ANALYZER
K935069 · Instrumentation Laboratory CO · Mar 1994
IL BG3 SYST, MODEL 1420, BLOOD GAS & PH TEST SYST
K913927 · Instrumentation Laboratory CO · Oct 1991
IL1400, BGELECTROLYTE ANALYZER
K890827 · Instrumentation Laboratory CO · Jun 1989
IL 1302 PH BLOOD GAS ANALYZER
K821483 · Instrumentation Laboratory CO · Jun 1982
IL MODEL 1301, PH BLOOD GAS SYSTEM
K820744 · Instrumentation Laboratory CO · Apr 1982
ARTERIAL MICROCOLLECTION SET
K810308 · American Dade · Feb 1981